Fenofibrate in Ulcerative Colitis
Condition: Inflammatory Bowel Diseases Interventions: Drug: Mesalamine; Drug: Fenofibrate 160mg Sponsors: Tanta University; Eman Ibrahim Elberri, Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University; Hend El-Said Abo Mansour, Biochemistry Department, Faculty of Pharmacy, Menoufia University; Monir Hussein Bahgat, Internal Medicine Department (Gastroenterology and Hepatology) , Faculty of Medicine, Mansura University; Eman Maamoun Ali El-Khateeb, Lecturer of Clinical Pharmacy, Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asacol | Biochemistry | Fenofibrate | Gastroenterology | Inflammatory Bowel Disease | Internal Medicine | Lialda | Men | Research | Tricor | Ulcerative Colitis